Core Laboratories (CLB) Stock Statistics & Valuation Metrics

Core Laboratories has a market cap or net worth of $615.85M. The enterprise value is $648.61M.

Core Laboratories has 46,096,684 shares outstanding. The number of shares has decreased by -2.65% in one year.

Core Laboratories’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.67%.

The current PE Ratio of Core Laboratories is 21.7. Core Laboratories’s PEG ratio is 16.83.

In the last 12 months, Core Laboratories had revenue of 526.52M and earned 29.67M in profits. Earnings per share was 0.68.

In the last 12 months, operating cash flow was 35.10M and capital expenditures -16.16M, giving a free cash flow of 18.94M billion.

Core Laboratories pays an annual dividend of $0.01, resulting in a dividend yield of 0.24%

Core Laboratories upcoming earnings date is Jul 29, 2026, After Close (Confirmed).

Core Laboratories as a current ratio of 2.07, with Debt / Equity ratio of 15.00%

In the past 12 months, Core Laboratories has paid 15.51M in taxes.

Core Laboratories EV to EBITDA ratio is 13.06, with an EV/FCF ratio of 41.12.

Core Laboratories has $22.82M in cash and marketable securities with $41.28M in debt, giving a net cash position of -$18.47M billion.

Gross margin is 17.84%, with operating margin of 9.59%, and net profit margin of 5.63%.

The average price target for Core Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―